Indaptus Therapeutics, Inc.
INDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,826 | $6,158 | $3,891 | $5,787 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $613 | $3 | $0 | $0 |
| Total Curr. Assets | $6,439 | $6,413 | $4,961 | $6,618 |
| Property Plant & Equip (Net) | $8 | $34 | $58 | $82 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $393 | $393 | $393 | $638 |
| Total NC Assets | $401 | $426 | $451 | $720 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,840 | $6,839 | $5,412 | $7,339 |
| Liabilities | – | – | – | – |
| Payables | $0 | $619 | $1,311 | $870 |
| Short-Term Debt | $9 | $6,503 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,226 | $0 | $83 | $0 |
| Total Curr. Liab. | $2,234 | $8,513 | $2,612 | $3,394 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $34 | $60 | $84 |
| Total Liabilities | $2,234 | $8,513 | $2,612 | $3,394 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $16 | $6 | $160 | $120 |
| Retained Earnings | -$73,176 | -$70,201 | -$64,972 | -$60,439 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $77,765 | $0 | $0 | $0 |
| Total Equity | $4,606 | -$1,673 | $2,800 | $3,945 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,840 | $6,839 | $5,412 | $7,339 |
| Net Debt | -$5,817 | $345 | -$3,891 | -$5,787 |